Anticoagulation and Antiplatelet Agents in Peripheral Arterial Interventions

Area of Science:

• Vascular Surgery
• Interventional Cardiology
• Pharmacology

Background:

• Peripheral artery disease (PAD) revascularization necessitates precise control of the clotting cascade.
• Post-procedural management is critical for optimizing patient outcomes and preventing complications.

Purpose of the Study:

• To guide interventionalists in selecting appropriate pharmacotherapy for post-revascularization management.
• To review anticoagulant and antiplatelet agents for patients with peripheral artery disease.

Main Methods:

• Review of current literature on anticoagulant and antiplatelet therapies.
• Discussion of patient-specific factors influencing medication choice, including cardiovascular risk, contraindications, and psychosocial elements.

Main Results:

• Effective revascularization depends on periprocedural pharmacological regulation.
• Individualized treatment plans considering patient factors are essential for post-revascularization care.
• Familiarity with available medication classes is crucial for improving cardiovascular outcomes.

Conclusions:

• Optimal post-revascularization management requires a tailored approach to pharmacotherapy.
• Anticoagulant and antiplatelet agents play a vital role in improving outcomes for PAD patients.
• Interventionalists must be knowledgeable about medication options to enhance patient cardiovascular health.